The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 21, 2017

Filed:

Oct. 11, 2013
Applicant:

Southern Research Institute, Birmingham, AL (US);

Inventor:

Subramaniam Ananthan, Birmingham, AL (US);

Assignee:

Southern Research Institute, Brimingham, AL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 239/26 (2006.01); C07D 401/12 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); A61K 31/496 (2006.01); C07D 295/13 (2006.01); C07D 215/06 (2006.01); C07D 239/30 (2006.01); C07D 239/74 (2006.01); C07D 401/04 (2006.01); C07D 403/12 (2006.01); C07D 401/14 (2006.01); C07D 211/60 (2006.01);
U.S. Cl.
CPC ...
C07D 295/13 (2013.01); C07D 211/60 (2013.01); C07D 215/06 (2013.01); C07D 239/26 (2013.01); C07D 239/30 (2013.01); C07D 239/74 (2013.01); C07D 401/04 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/12 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01);
Abstract

Provided are compounds represented by the formula: with Y, Ri, and R2 being defined in the present disclosure; pharmaceutically acceptable salts thereof, deuterated forms thereof, isomers thereof, solvates thereof, and mixtures thereof. The compounds can be used for treating a patient suffering from a condition capable of treatment with a partial agonist or antagonist of the dopamine D2/D3 receptors and are especially useful for patients suffering from schizophrenia, depressions, neurodegenerative diseases such as Parkinson's, dyskinesias, substance abuse and relapse to substance abuse and addiction to substances such as cocaine, methamphetamine, nicotine and alcohol, glaucoma, cognitive disorders, restless leg syndrome, attention deficit hyperactivity disorders, hyperprolactinemia, autism, motor disturbances such as akathisia, rigor, dystonias as well as various disorders of the urinary tract and other neurologic disorders. Also provided are processes for the preparation of compounds of the present disclosure.


Find Patent Forward Citations

Loading…